Hirofumi Suwa
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 10
- Cancer-related Molecular Pathways 6
- HER2/EGFR in Cancer Research 3
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 6
- Breast Cancer Treatment Studies 4
- Immunology and Allergy top 10%
- Pathology and Forensic Medicine top 10%
- Breast Lesions and Carcinomas 4
-
- Glycosylation and Glycoproteins Research 3
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 3
- Co-authors
- Gakuji OhshioManabu FukumotoMasayuki ImamuraTakashi ImamuraH HiaiShigeki AriiMichio ImamuraGo Watanabe
- Partner nations
- JapanUnited States
In The Last Decade
Hirofumi Suwa
39 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 90
- Oncology 512
- Cancer Research 263
- Immunology and Allergy 60
- Pathology and Forensic Medicine 135
- Cell Biology 93
Countries citing papers authored by Hirofumi Suwa
This map shows the geographic impact of Hirofumi Suwa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hirofumi Suwa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hirofumi Suwa more than expected).
Fields of papers citing papers by Hirofumi Suwa
This network shows the impact of papers produced by Hirofumi Suwa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hirofumi Suwa. The network helps show where Hirofumi Suwa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hirofumi Suwa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 2 | |
| 2 | 2022 | 13 | |
| 3 | 2013 | 123 | |
| 4 | 2008 | 1 | |
| 5 | 2008 | 1 | |
| 6 | 2007 | 2 | |
| 7 | 2007 | 4 | |
| 8 | 2002 | 1 | |
| 9 | 1999 | 7 | |
| 10 | 1998 | 243 | |
| 11 | 1998 | 31 | |
| 12 | 1997 | 44 | |
| 13 | 1997 | 9 | |
| 14 | 1996 | 56 | |
| 15 | 1996 | 35 | |
| 16 | 1996 | 35 | |
| 17 | 1995 | 61 | |
| 18 | 1994 | 28 | |
| 19 | 1994 | 13 | |
| 20 | 1993 | 9 |
About Hirofumi Suwa
Hirofumi Suwa is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 43 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (10 papers), Cancer Genomics and Diagnostics (6 papers), Cancer-related Molecular Pathways (6 papers), Breast Lesions and Carcinomas (4 papers), Breast Cancer Treatment Studies (4 papers), Glycosylation and Glycoproteins Research (3 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Oncology (512 citations), Cancer Research (263 citations) and Immunology and Allergy (60 citations). Hirofumi Suwa has collaborated with scholars based in Japan and United States. Frequent co-authors include Gakuji Ohshio, Manabu Fukumoto, Masayuki Imamura, Takashi Imamura, H Hiai, Shigeki Arii, Michio Imamura, Go Watanabe, Shuh Narumiya and Takashi Imamura.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.